NEWS & EVENTS

Latest news and upcoming events

Memo Therapeutics increases Series C financing to CHF 45 million
07 May 2024

Memo Therapeutics increases Series C financing to CHF 45 million

Upcoming events

  • Bio€quity Europe
    14 - 16 May 2024,
    San Sebastián

    download

  • AseBio Investor Day 2024
    15 May 2024,
    San Sebastián

    download

  • ESMO Congress 2024
    13 - 19 September 2024,
    Barcelona

    download
ONA Therapeutics appoints Mark Throsby to its Board of Directors<
05 Mar 2021

ONA Therapeutics appoints Mark Throsby to its Board of Directors

Dr. Mark Throsby is a biopharmaceutical executive with extensive research experience and a track record of innovation and execution.
New Data Supports High Reperfusion Rate for Anaconda Biomed’s Mechanical Thrombectomy System<
17 Feb 2021

New Data Supports High Reperfusion Rate for Anaconda Biomed’s Mechanical Thrombectomy System

In Vitro Study, Showing Suction Force Correlates with Reperfusion in Hard Clots, Published in Journal of NeuroInterventional Surgery
MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman<
10 Feb 2021

MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman

Financing to advance optically-guided real-time ablation catheter technology for the treatment of Atrial Fibrillation.
10 Feb 2021

Sanifit Granted Orphan Drug Designation by the FDA for SNF472 for the Treatment of Peripheral Arterial Disease in Patients with End-stage Kidney Disease

Sanifit today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead compound SNF472 for the treatment of peripheral arterial disease (PAD) in patients with end-stage kidney disease (ESKD).
09 Feb 2021

CorWave Joins the French Tech 120 Index, a Community That Brings Together the Top French Tech Scale-up Companies

The company develops breakthrough cardiac pumps with the aim of improving the lives of advanced heart failure patients
Renowned Pioneers in Ophthalmology Join SparingVision’s Scientific Advisory Board<
29 Jan 2021

Renowned Pioneers in Ophthalmology Join SparingVision’s Scientific Advisory Board

Development of lead asset SPVN06 to further benefit from high-level Clinical Advisory Board.
27 Jan 2021

VarmX appoints Dr. Gerard Short as Chief Medical Officer

VarmX today announces the appointment of Dr. Gerard Short, MBBS, as Chief Medical Officer (CMO).
Minoryx presents topline results from Phase 2/3 “ADVANCE” study demonstrating significant clinical benefit of leriglitazone in adrenomyeloneuropathy (AMN)<
26 Jan 2021

Minoryx presents topline results from Phase 2/3 “ADVANCE” study demonstrating significant clinical benefit of leriglitazone in adrenomyeloneuropathy (AMN)

Minoryx Therapeutics today announces that a lead investigator of the Minoryx Phase 2/3 ADVANCE clinical trial will present further results of the study at the 2021 Virtual Annual Meeting of the American Neurological Association.
Inbiomotion raises an oversubscribed financing round to launch its diagnostic product in breast cancer<
21 Jan 2021

Inbiomotion raises an oversubscribed financing round to launch its diagnostic product in breast cancer

IInbiomotion SL today announced that Alta Life Sciences has led a significantly oversubscribed investment round in the company.
Splice Bio appoints Jean-Philippe Combal as Chairman of the Board of Directors<
21 Jan 2021

Splice Bio appoints Jean-Philippe Combal as Chairman of the Board of Directors

Dr. Combal is a proven senior executive and biotechnology entrepreneur with 30 years of experience.

Newsletter

subscribe

Subscribe to our weekly newsletter for the latest
updates on life sciences investments.

Bitplex 360 Кракен даркнет кракен даркнет Blacksprut Blacksprut Кракен ссылка кракен ссылка